(All fields required)
Please enter a valid email.
Please enter your name.
At Cincinnati Children’s, we recognize the differences and challenges of treating young adults with inflammatory bowel disease, particularly those between the ages of 13 and 18 when self-management is critical. Thanks to our unique diagnostic abilities and pediatric expertise, we are a leading national referral center for complicated inflammatory bowel disease / IBD management.
The depth and breadth of services we offer are unparalleled, as Cincinnati Children’s is one of the few children’s hospitals that offers an IBD focus within Gastroenterology, Surgery, Pain Management and Psychology.
One of our strengths is our diversity: our team members come together from multiple disciplines to address pediatric IBD issues. We are also privileged to partner with surgeons at Cincinnati Children’s who specialize in the correction of pediatric colorectal disorders. And since the best care is provided when primary care physicians and families partner with our specialists to make medical decisions, we work closely with referring physicians to plan comprehensive strategies for care.
Pediatric evidence-based care guidelines have been developed at Cincinnati Children's by a team of gastroenterologists, clinical effectiveness physicians, and evidence-based experts working together with patients and families. These guidelines are used by our care team and also help pediatricians provide the best possible care to inflammatory bowel disease patients. Our goal in developing them was to set a standard of care that is evidence-based, efficient, family-centered and safe.
We believe in providing family-centered care where health care providers and the family are partners -- working together to best meet the need of the child. Our inflammatory bowel disease specialists educate patients and families and assist with quality-of-life issues. Available resources include:
Our nurses are specially trained in the field of pediatric gastroenterology.
ImproveCareNow is a network
of pediatric IBD centers across the country, Canada and the UK dedicated to the improvement the care and health of all
children and adolescents with Crohn’s disease and ulcerative colitis.
Crohn's and Colitis Foundation of America (CCFA): The CCFA is a non-profit, volunteer-driven
organization dedicated to finding the cures for Crohn's
Disease and ulcerative
As part of the Division of Gastroenterology, Hepatology and Nutrition, we’re committed to providing our field with the next generation of industry-leading clinicians and researchers. Learn more about our training programs and fellowships.
As part of our mission to improve the lives of children with inflammatory bowel disease, members of the Division of Gastroenterology, Hepatology and Nutrition actively pursue research, including various aspects of IBD causes and treatment. Current studies include:
Risk stratification and identification of
immunogenetic and microbial markers of rapid disease progression in children with Crohn’s disease.This
multi-center project will define genetic, genomic, microbial, and immune
markers of disease progression in children with newly diagnosed Crohn’s Disease.
Telehealth Enhancement of Adherence to Medication in Pediatric IBD
(TEAM Study)The primary goal of this multi-center study is
to test the efficacy of a telehealth behavioral treatment on medication adherence
in children and adolescents with IBD.
Predicting Response to Standardized Pediatric
Colitis Therapy: The PROTECT StudyThis project will conduct a prospective multi-center
clinical trial of standardized medical therapy in pediatric Ulcerative Colitis
and will identify genetic and immune predictors of response.
Environment, and Microbes StudyThis prospective multi-center case-control
study will determine differences in genetic polymorphisms, environmental
exposures, and the microbial community between first degree relatives of Crohn’s
Disease patients who developed IBD and those who do not
the gut microbial ecosystem for diagnosis and therapy in IBDThis multi-center project will assess the
composition and biomolecular activity of gut microbes in IBD patients over time
using many different experimental techniques, which will be combined to provide
an extensive data resource aiding our understanding of the disease.
Learn more about our current studies and projects.
Lee (Ted) Denson, MD, researches growth hormone therapy to treat pediatric Crohn's disease.
Your gift to the IBD Center will support the Division of Gastroenterology, Hepatology and Nutrition. It will be processed in a completely secure environment.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center